CRL 05/21 13:41 AXA IM UK: ASTRAZENECA SHOULD NOT PREVENT OFFER PUT TO HOLDERS
BN 05/21 13:39 *AXA INVESTMENT MANAGERS UK COMMENTS IN E-MAIL STATEMENT
BN 05/21 13:39 *AXA INVESTMENT MANAGERS UK'S JIM STRIDE COMMENTS ON PFE/AZN
BN 05/21 13:37 *AXA IM UK SAYS AZN BOARD 'ARGUABLY WRONG' TO DISMISS PROPOSAL
BN 05/21 13:37 *AXA IM UK SAYS MANY SHAREHOLDERS WILL FIND OFFER ATTRACTIVE
BN 05/21 13:36 *AXA IM UK REFERS TO 55-POUND-SHARE OFFER
BN 05/21 13:36 *AXA IM UK: ASTRAZENECA SHOULD NOT PREVENT OFFER PUT TO HOLDERS
BN 05/21 13:34 *AXA INVESTMENT MANAGERS UK COMMENTS ON PFIZER-ASTRAZENECA
BN 05/21 13:39 *AXA INVESTMENT MANAGERS UK COMMENTS IN E-MAIL STATEMENT
BN 05/21 13:39 *AXA INVESTMENT MANAGERS UK'S JIM STRIDE COMMENTS ON PFE/AZN
BN 05/21 13:37 *AXA IM UK SAYS AZN BOARD 'ARGUABLY WRONG' TO DISMISS PROPOSAL
BN 05/21 13:37 *AXA IM UK SAYS MANY SHAREHOLDERS WILL FIND OFFER ATTRACTIVE
BN 05/21 13:36 *AXA IM UK REFERS TO 55-POUND-SHARE OFFER
BN 05/21 13:36 *AXA IM UK: ASTRAZENECA SHOULD NOT PREVENT OFFER PUT TO HOLDERS
BN 05/21 13:34 *AXA INVESTMENT MANAGERS UK COMMENTS ON PFIZER-ASTRAZENECA
AstraZeneca Should Put Pfizer Offer to Holders, AXA IM Says
2014-05-21 13:42:28.861 GMT
By Gaurav Panchal
May 21 (Bloomberg) -- AXA Investment Managers U.K. says
AstraZeneca board should not prevent an offer from Pfizer of
5,500p-shr from being put to the shareholders of the company
* Many shareholders, but not necessarily all, will find this
an attractive offer: AXA
* AstraZeneca board was arguably wrong, acted too hastily to
dismiss latest proposal from Pfizer: AXA
* Says has met with the management teams of Pfizer and
AstraZeneca in recent past
* Comments from Jim Stride, director and head of U.K.
equities, AXA Investment Managers U.K.
* Statement here
* AXA owns 5.45% of AstraZeneca: Bloomberg data
For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>
--With assistance from Trista Kelley in London.
To contact the reporter on this story:
Gaurav Panchal in London at +44-20-7392-0511 or
gpanchal2@bloomberg.net
To contact the editors responsible for this story:
James Ludden at +44-20-7673-2645 or
jludden@bloomberg.net
Brian Lysaght
2014-05-21 13:42:28.861 GMT
By Gaurav Panchal
May 21 (Bloomberg) -- AXA Investment Managers U.K. says
AstraZeneca board should not prevent an offer from Pfizer of
5,500p-shr from being put to the shareholders of the company
* Many shareholders, but not necessarily all, will find this
an attractive offer: AXA
* AstraZeneca board was arguably wrong, acted too hastily to
dismiss latest proposal from Pfizer: AXA
* Says has met with the management teams of Pfizer and
AstraZeneca in recent past
* Comments from Jim Stride, director and head of U.K.
equities, AXA Investment Managers U.K.
* Statement here
* AXA owns 5.45% of AstraZeneca: Bloomberg data
For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>
--With assistance from Trista Kelley in London.
To contact the reporter on this story:
Gaurav Panchal in London at +44-20-7392-0511 or
gpanchal2@bloomberg.net
To contact the editors responsible for this story:
James Ludden at +44-20-7673-2645 or
jludden@bloomberg.net
Brian Lysaght